Novo Nordisk Inks License Agreement For Sickle Cell Disease Candidate

Benzinga04:05

IMMvention Therapeutix Enters Collaboration With Novo Nordisk for Sickle Cell Disease Therapies

Seeking AlphaJan 22 21:59

GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares Rise

Zacks Jan 22 21:00

Novo Nordisk to Further Scale Up Production, Supply, Employment -- Market Talk

WSJJan 22 18:24

GLP-1 Weight Loss Drugs Linked to a Wide Range of Health Benefits and Risks: Study

Seeking AlphaJan 22 00:06

$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today

BenzingaJan 21 23:15